SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalXRAY - Undiscovered Gem


Previous 10 Next 10 
To: John Ritter who wrote (31)6/9/1998 1:53:00 PM
From: Mike Roberts
   of 47
 
They are the INtel of the dental suppliers without as many lawsuits! Looking at the chart, the recent drop erased one full year of steady gains. Also, compared to the medical industry, it seems cheap at 19X earnings. XRAY should retrace 50% of its drop over next two weeks unless the earnings warnings were optimistic.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Mike Roberts who wrote (32)6/10/1998 10:45:00 PM
From: Henrik
   of 47
 
XRAY - Additional stock buy back
This could help the stock price along.
biz.yahoo.com
Henrik

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Henrik who wrote (33)7/24/1998 7:02:00 PM
From: Henrik
   of 47
 
XRAY on the way to recovery ??
Up 4% on the day.
Is XRAY on the way back after the freefall in late May ?
Insiders were busy buying stock in the past month or so.
Apart from the additional buy back announced July 23 are there any other news out there.
Henrik

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Henrik who wrote (34)2/27/1999 11:37:00 PM
From: TonyAylward
   of 47
 
Any one awake out there in XRAY land? I just bought this stock when it popped up through my screen.......What so good about XRAY right now? looks like a good chance of a technical rebound since the consumer non-cyclical group is on the up over the past month while XRAY itself is on a down draught against its own intact 30-day up trend. OK, so why buy it? Value mainly:-
1) Current price $25 versus est.value $30 = p/e 18(historic vs. 15 current)*$1.72 estimated current eps

2) low P/e - to - growth ratio 15 / 16%
3) low debt - will never go bankrupt

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: TonyAylward who wrote (35)2/28/1999 9:16:00 PM
From: Henrik
   of 47
 
Tony,

I have been out of XRAY since late last year.
No other reason than lack of price movement / action in the stock.

>>I just bought this stock when it popped up through my screen<<
How ?? scanning for value, p/e or what caused it it 'pop' up on your screen ??
Henrik

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Henrik who wrote (36)3/7/1999 6:29:00 PM
From: TonyAylward
   of 47
 
Well, as per my first email, I first did a technical scan to choose all technically strong stocks in technical strong groups in trechnically strong industries and then veted that selection for fundamental soundness - not over valued earnings not tanking not over levered......thus XRAY!!:-)

Share RecommendKeepReplyMark as Last Read


From: Dr_of_Microcaps2/22/2012 6:27:58 AM
   of 47
 
finance.yahoo.com

Share RecommendKeepReplyMark as Last Read


From: Dr_of_Microcaps8/1/2012 11:23:41 PM
   of 47
 
finance.yahoo.com

Share RecommendKeepReplyMark as Last Read


From: Dr_of_Microcaps8/21/2013 12:40:54 PM
   of 47
 
DENTSPLY International Reports Second Quarter 2013 Results Press Release: DENTSPLY International Inc. – Thu, Aug 1, 2013 6:33 AM EDT 0





RELATED QUOTES
SymbolPriceChange
XRAY41.87+0.08









  • Earnings per diluted share of $0.60 on a US GAAP reported basis and a record $0.66 on an adjusted basis

  • Adjusted operating margin expanded 60 basis points to 19.2% from 18.6% in the prior year

York, PA - August 1, 2013 - DENTSPLY International Inc. ( XRAY) today announced sales and earnings for the three months ended June 30, 2013.

Net sales in the second quarter of 2013 were essentially flat at $761.0 million compared to $763.0 million in the second quarter of 2012. Net sales, excluding precious metals content, in the second quarter of 2013 of $716.0 million increased 2.5% from $698.5 million in the second quarter of 2012. Constant currency net sales growth, excluding precious metals content, in the second quarter was 2.7%, reflecting strong internal growth in the U.S. and more modest internal growth in the other geographic regions.

Net income attributable to DENTSPLY International for the second quarter of 2013 was $87.2 million, or $0.60 per diluted share, compared to $80.8 million, or $0.56 per diluted share in the second quarter of 2012. On an adjusted basis, excluding certain items, earnings grew 7% to $0.66 per diluted share for the second quarter of 2013 from $0.62 in the same period in 2012. A reconciliation of the non-GAAP measure to earnings per share calculated on a US GAAP basis is provided in the attached table.

"DENTSPLY achieved record adjusted earnings for the second quarter driven by an acceleration of internal growth in the U.S. and expansion of adjusted operating margins," said Bret Wise, Chairman and Chief Executive Officer. "Although we are pleased with our second quarter performance, market conditions continue to be difficult in Europe and movement of currency exchange rates has created some further headwind in the second half of the year. As a result, we are revising our expectations for adjusted earnings per share for 2013 to a range of $2.33 to $2.38."

Additional Information

A conference call is scheduled to begin today at 8:30 a.m. (Eastern Time). Supplemental materials for reference during the call will be available for download in the investor relations section of DENTSPLY`s web site, at www.dentsply.com.

A live webcast will be accessible via a link on DENTSPLY`s web site at www.dentsply.com. In order to participate in the call, dial (888) 417-2254 for domestic calls, or (719) 325-2490 for international calls. The Conference ID # is 1879202. At that time, you will be able to discuss second quarter 2013 results with DENTSPLY`s Chairman and Chief Executive Officer, Mr. Bret Wise, President and Chief Financial Officer, Mr. Chris Clark, and Executive Vice President and Chief Operating Officer, Mr. Jim Mosch.

A rebroadcast of the conference call will be available online at the DENTSPLY web site. You may also access a dial-in replay for one week following the call at (888) 203-1112 (for domestic calls) or (719) 457-0820 (for international calls), Replay Passcode # 1879202.

DENTSPLY International Inc. is a leading manufacturer and distributor of dental and other consumable medical device products. The Company believes it is the world`s largest manufacturer of consumable dental products for the professional dental market. For over 110 years, DENTSPLY`s commitment to innovation and professional collaboration has enhanced its portfolio of branded consumables and small equipment. Headquartered in the United States, the Company has global operations with sales in more than 120 countries. Visit www.dentsply.com for more information about DENTSPLY and its products.

This press release contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties. Actual events or results may differ materially from those in the projections or other forward-looking information set forth herein as a result of certain risk factors. These risk factors include, without limitation; the continued strength of dental and medical markets, the timing, success and market reception for our new and existing products, uncertainty with respect to governmental actions with respect to dental and medical products, outcome of litigation and/or governmental enforcement actions, continued support of our products by influential dental and medical professionals, our ability to successfully integrate acquisitions, risks associated with foreign currency exchange rates, and changes in the general economic environment that could affect the business. Changes in such assumptions or factors could produce significantly different results.

For an additional description of risk factors, please refer to the Company`s most recent Form 10-K and its subsequent periodic reports on Forms 10-Q filed with the Securities and Exchange Commission.

Non-US GAAP Financial Measures

In addition to the results reported in accordance with US GAAP, the Company provides adjusted net income attributable to DENTSPLY International and adjusted earnings per diluted common share. The Company discloses adjusted net income attributable to DENTSPLY International to allow investors to evaluate the performance of the Company`s operations exclusive of certain items that impact the comparability of results from period to period and certain large non-cash charges related to purchased intangible assets. The Company believes that this information is helpful in understanding underlying operating trends and cash flow generation. The adjusted net income attributable to DENTSPLY International consists of net income attributable to DENTSPLY International adjusted to exclude the impact of the following:

(1) Acquisition related costs. These adjustments include costs related to integrating recently acquired businesses and specific costs related to the consummation of the acquisition process. These costs are irregular in timing and as such may not be indicative of past and future performance of the Company and are therefore excluded to allow investors to better understand underlying operating trends.

(2) Restructuring and other costs, including legal settlements. These adjustments include both costs and income that are irregular in timing, amount and impact to the Company`s financial performance. As such, these items may not be indicative of past and future performance of the Company and are therefore excluded for the purpose of understanding underlying operating trends.

(3) Amortization of purchased intangible assets. This adjustment excludes the periodic amortization expense related to purchased intangible assets. Following a significant acquisition in 2011, the Company began recording large non-cash charges related to the values attributed to purchased intangible assets. These charges have been excluded from adjusted net income attributed to DENTSPLY International to allow investors to evaluate and understand operating trends excluding these large non-cash charges.

(4) Income related to credit risk and fair value adjustments. These adjustments include both the cost and income impacts of adjustments in certain assets and liabilities that are recorded through net income which are due solely to the changes in fair value and credit risk. These items can be variable and driven more by market conditions than the Company`s operating performance. As such, these items may not be indicative of past and future performance of the Company and therefore are excluded for comparability purposes.

(5) Certain fair value adjustments at an unconsolidated affiliated company. This adjustment represents the fair value adjustment of the unconsolidated affiliated company`s convertible debt instrument held by the Company. The affiliate is accounted for under the equity method of accounting. The fair value adjustment is driven by open market pricing of the affiliate`s equity instruments, which has a high degree of variability and may not be indicative of the operating performance of the affiliate or the Company.

(6) Income tax related adjustments. These adjustments include both income tax expenses and income tax benefits that are representative of income tax adjustments mostly related to prior periods, as well as the final settlement of income tax audits. These adjustments are irregular in timing and amount and may significantly impact the Company`s operating performance. As such, these items may not be indicative of past and future performance of the Company and therefore are excluded for comparability purposes.

Adjusted earnings per diluted common share is calculated by dividing adjusted net income attributable to DENTSPLY International by diluted weighted-average common shares outstanding. Adjusted net income attributable to DENTSPLY International and adjusted earnings per diluted common share are considered measures not calculated in accordance with US GAAP, and therefore are non-US GAAP measures. These non-US GAAP measures may differ from other companies. Income tax related adjustments may include the impact to adjust the interim effective income tax rate to the expected annual effective tax rate. The non-US GAAP financial information should not be considered in isolation from, or as a substitute for, measures of financial performance prepared in accordance with US GAAP.

DENTSPLY INTERNATIONAL INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
Three Months Ended Six Months Ended
June 30, June 30,
2013 2012 2013 2012
Net sales $ 761,010 $ 762,994 $ 1,493,094 $ 1,479,407
Net sales, excluding precious metal content 715,956 698,480 1,388,604 1,364,105
Cost of products sold 346,054 355,525 689,938 679,188
Gross profit 414,956 407,469 803,156 800,219
% of Net sales 54.5 % 53.4 % 53.8 % 54.1 %
% of Net sales, excluding precious metal content 58.0 % 58.3 % 57.8 % 58.7 %
Selling, general and administrative expenses 289,921 296,034 583,598 600,388
Restructuring and other costs 2,169 2,528 2,834 3,765
Operating income 122,866 108,907 216,724 196,066
% of Net sales 16.1 % 14.3 % 14.5 % 13.3 %
% of Net sales, excluding precious metal content 17.2 % 15.6 % 15.6 % 14.4 %
Net interest and other expense 13,487 13,321 29,451 27,288
Income before income taxes 109,379 95,586 187,273 168,778
Provision for income taxes 22,870 14,875 26,412 29,590
Equity in net earnings (loss) of
unconsolidated affiliated company 2,182 1,329 403 (2,919 )
Net income 88,691 82,040 161,264 136,269
% of Net sales 11.7 % 10.8 % 10.8 % 9.2 %
% of Net sales, excluding precious metal content 12.4 % 11.7 % 11.6 % 10.0 %
Less: Net income attributable to noncontrolling interests 1,463 1,276 2,351 2,220
Net income attributable to DENTSPLY International $ 87,228 $ 80,764 $ 158,913 $ 134,049
% of Net sales 11.5 % 10.6 % 10.6 % 9.1 %
% of Net sales, excluding precious metal content 12.2 % 11.6 % 11.4 % 9.8 %
Earnings per common share:
Basic $ 0.61 $ 0.57 $ 1.11 $ 0.95
Dilutive $ 0.60 $ 0.56 $ 1.10 $ 0.93
Cash dividends declared per common share $ 0.0625 $ 0.0550 $ 0.1250 $ 0.1100
Weighted average common shares outstanding:
Basic 142,922 141,737 142,849 141,729
Dilutive 145,133 143,863 145,107 143,908

DENTSPLY INTERNATIONAL INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
June 30, December 31,
2013 2012
Assets
Current Assets:
Cash and cash equivalents $ 57,027 $ 80,132
Accounts and notes receivable-trade, net 499,006 442,412
Inventories, net 433,189 402,940
Prepaid expenses and other current assets 180,811 185,612
Total Current Assets 1,170,033 1,111,096
Property, plant and equipment, net 605,028 614,705
Identifiable intangible assets, net 786,667 830,642
Goodwill, net 2,158,529 2,210,953
Other noncurrent assets, net 154,426 204,901
Total Assets $ 4,874,683 $ 4,972,297
Liabilities and Equity
Current liabilities $ 890,615 $ 927,780
Long-term debt 1,123,792 1,222,035
Deferred income taxes 218,624 232,641
Other noncurrent liabilities 353,556 340,398
Total Liabilities 2,586,587 2,722,854
Total DENTSPLY International Equity 2,250,185 2,208,698
Noncontrolling interests 37,911 40,745
Total Equity 2,288,096 2,249,443
Total Liabilities and Equity $ 4,874,683 $ 4,972,297

DENTSPLY INTERNATIONAL INC.
(In thousands)
Supplemental Summary Cash Flow Information:
Six Months Ended June 30, 2013
Six Months Ended June 30,
2013 2012
Net Cash Provided by Operating Activities $ 131,868 $ 103,395
Net Cash Used in Investing Activities $ 136,188 $ 58,507
Net Cash Used in Financing Activities $ 15,436 $ 67,414
Depreciation $ 41,743 $ 40,357
Amortization $ 23,434 $ 28,014
Capital Expenditures $ 46,151 $ 42,986
Cash Dividends Paid $ 16,928 $ 15,706

DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Income Summary:
The following tables present the reconciliation of reported US GAAP operating income in total and on a percentage of net sales, excluding precious metal content, to the non-US GAAP financial measures.
Three Months Ended June 30, 2013
Operating Income (Loss) Percentage of Net Sales, Excluding Precious Metal Content
Operating Income $ 122,866 17.2 %
Amortization of Purchased Intangible Assets 11,480 1.5 %
Restructuring and Other Costs, including Legal Settlements 2,285 0.3 %
Acquisition-Related Activities 1,132 0.2 %
Adjusted Non-US GAAP Operating Income $ 137,763 19.2 %
Three Months Ended June 30, 2012
Operating Income (Loss) Percentage of Net Sales, Excluding Precious Metal Content
Operating Income $ 108,907 15.6 %
Amortization of Purchased Intangible Assets 12,685 1.9 %
Acquisition-Related Activities 4,902 0.7 %
Restructuring and Other Costs 2,910 0.4 %
Orthodontic Business Continuity Costs 345 - %
Adjusted Non-US GAAP Operating Income $ 129,749 18.6 %
DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Income Summary:
The following tables present the reconciliation of reported US GAAP operating income in total and on a percentage of net sales, excluding precious metal content, to the non-US GAAP financial measures.
Six Months Ended June 30, 2013
Operating Income (Loss) Percentage of Net Sales, Excluding Precious Metal Content
Operating Income $ 216,724 15.6 %
Amortization of Purchased Intangible Assets 23,415 1.6 %
Acquisition-Related Activities 3,269 0.3 %
Restructuring and Other Costs, including Legal Settlements 3,058 0.2 %
Adjusted Non-US GAAP Operating Income $ 246,466 17.7 %
Six Months Ended June 30, 2012
Operating Income (Loss) Percentage of Net Sales, Excluding Precious Metal Content
Operating Income $ 196,066 14.4 %
Amortization of Purchased Intangible Assets 28,047 2.1 %
Acquisition-Related Activities 12,436 1.0 %
Restructuring and Other Costs 4,640 0.3 %
Orthodontic Business Continuity Costs 961 - %
Adjusted Non-US GAAP Operating Income $ 242,150 17.8 %

DENTSPLY INTERNATIONAL INC.
(In thousands, except per share amounts)
Earnings Summary:
The following tables present the reconciliation of reported US GAAP net income attributable to DENTSPLY International and on a per common share basis to the non-US GAAP financial measures.
Three Months Ended June 30, 2013
Net Per Diluted
Income Common Share
Net Income Attributable to DENTSPLY International $ 87,228 $ 0.60
Amortization of Purchased Intangible Assets, Net of Tax 8,002 0.06
Restructuring and Other Costs, including Legal Settlements, Net of Tax 1,962 0.01
Acquisition Related Activities, Net of Tax 746 0.01
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax 457 -
Income Tax-Related Adjustments (118 ) -
Gain on Fair Value Adjustments at an Unconsolidated Affiliated Company, Net of Tax (2,446 ) (0.02 )
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International $ 95,831 $ 0.66
Three Months Ended June 30, 2012
Net Per Diluted
Income Common Share
Net Income Attributable to DENTSPLY International $ 80,764 $ 0.56
Amortization of Purchased Intangible Assets, Net of Tax 9,007 0.06
Acquisition Related Activities, Net of Tax 2,993 0.02
Restructuring and Other Costs, Net of Tax 1,990 0.02
Orthodontics Business Continuity Costs, Net of Tax 213 -
Gain on Fair Value Adjustments at an Unconsolidated Affiliated Company, Net of Tax (1,060 ) (0.01 )
Income Tax-Related Adjustments (5,380 ) (0.03 )
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International $ 88,527 $ 0.62
DENTSPLY INTERNATIONAL INC.
(In thousands, except per share amounts)
Earnings Summary:
The following tables present the reconciliation of reported US GAAP net income attributable to DENTSPLY International and on a per common share basis to the non-US GAAP financial measures.
Six Months Ended June 30, 2013
Net Per Diluted
Income Common Share
Net Income Attributable to DENTSPLY International $ 158,913 $ 1.10
Amortization of Purchased Intangible Assets, Net of Tax 16,378 0.11
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax 3,190 0.02
Restructuring and Other Costs, including Legal Settlements, Net of Tax 2,501 0.02
Acquisition Related Activities, Net of Tax 2,099 0.01
Gain on Fair Value Adjustments at an Unconsolidated Affiliated Company, Net of Tax (519 ) -
Income Tax-Related Adjustments (11,505 ) (0.08 )
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International $ 171,057 $ 1.18
Six Months Ended June 30, 2012
Net Per Diluted
Income Common Share
Net Income Attributable to DENTSPLY International $ 134,049 $ 0.93
Amortization of Purchased Intangible Assets, Net of Tax 19,989 0.14
Acquisition Related Activities, Net of Tax 7,789 0.05
Loss on Fair Value Adjustments at an Unconsolidated Affiliated Company, Net of Tax 3,595 0.03
Restructuring and Other Costs, Net of Tax 3,154 0.02
Orthodontics Business Continuity Costs, Net of Tax 621 -
Income Tax-Related Adjustments (5,414 ) (0.03 )
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International $ 163,783 $ 1.14

DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Tax Rate Summary:
The following tables present the reconciliation of reported US GAAP effective tax rate as a percentage of income before income taxes to the non-US GAAP financial measure.
Three Months Ended June 30, 2013
Pre-tax Income Income Tax Benefit (Expense) Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results $ 109,379 $ (22,870 ) 20.9 %
Amortization of Purchased Intangible Assets 11,480 (3,478 )
Restructuring and Other Costs, including Legal Settlements 2,285 (323 )
Acquisition-Related Activities 1,132 (386 )
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax 744 (287 )
Gain on Fair Value Adjustments at an Unconsolidated Affiliated Company (45 ) 14
Income Tax-Related Adjustments - (118 )
As Adjusted - Non-US GAAP Operating Results $ 124,975 $ (27,448 ) 22.0 %
Three Months Ended June 30, 2012
Pre-tax Income Income Tax Benefit (Expense) Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results $ 95,586 $ (14,875 ) 15.6 %
Amortization of Purchased Intangible Assets 12,685 (3,678 )
Acquisition-Related Activities 4,902 (1,909 )
Restructuring and Other Costs 2,910 (920 )
Orthodontics Business Continuity Costs, Net of Tax 345 (132 )
Gain on Fair Value Adjustments at an Unconsolidated Affiliated Company (95 ) 30
Income Tax-Related Adjustments - (5,378 )
As Adjusted - Non-US GAAP Operating Results $ 116,333 $ (26,862 ) 23.1 %
DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Tax Rate Summary:
The following tables present the reconciliation of reported US GAAP effective tax rate as a percentage of income before income taxes to the non-US GAAP financial measure.
Six Months Ended June 30, 2013
Pre-tax Income Income Tax Benefit (Expense) Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results $ 187,273 $ (26,412 ) 14.1 %
Amortization of Purchased Intangible Assets 23,415 (7,037 )
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax 5,195 (2,005 )
Acquisition-Related Activities 3,269 (1,170 )
Restructuring and Other Costs, including Legal Settlements 3,058 (557 )
Gain on Fair Value Adjustments at an Unconsolidated Affiliated Company (13 ) 4
Income Tax-Related Adjustments - (11,505 )
As Adjusted - Non-US GAAP Operating Results $ 222,197 $ (48,682 ) 21.9 %
Six Months Ended June 30, 2012
Pre-tax Income Income Tax Benefit (Expense) Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results $ 168,778 $ (29,590 ) 17.5 %
Amortization of Purchased Intangible Assets 28,047 (8,058 )
Acquisition-Related Activities 12,436 (4,647 )
Restructuring and Other Costs 4,640 (1,486 )
Orthodontics Business Continuity Costs, Net of Tax 961 (340 )
Loss on Fair Value Adjustments at an Unconsolidated Affiliated Company 178 (54 )
Income Tax-Related Adjustments - (5,414 )
As Adjusted - Non-US GAAP Operating Results $ 215,040 $ (49,589 ) 23.1 %
For further information contact:

Derek Leckow
Vice President
Investor Relations
(717) 849-7863

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Share RecommendKeepReplyMark as Last Read


From: Dr_of_Microcaps2/3/2014 9:17:44 PM
   of 47
 
DENTSPLY International Reports Record Third Quarter 2013 Results


DENTSPLY International Inc.October 29, 2013 7:02 AM







Third quarter adjusted earnings per diluted share increased 12% to $0.57 compared to $0.51

Adjusted operating margin expanded 60 basis points to 17.9% from 17.3% in the prior year third quarter

Operating cash flow improved by 31% to $126 million for the third quarter and grew 28% to $258 million through nine months

York, PA - October 29, 2013 - DENTSPLY International Inc. ( XRAY) today announced record sales and earnings for the three months ended September 30, 2013.

Net sales in the third quarter of 2013 grew 1.2% to $704.0 million compared to $695.7 million in the third quarter of 2012. Excluding precious metals content, net sales in the third quarter of 2013 of $669.4 million grew 3.4% from $647.1 million in the third quarter of 2012. Constant currency net sales growth, excluding precious metals content, in the third quarter was 2.7%, reflecting strong internal growth in the U.S. and Rest of World geographic regions and continued slightly positive internal growth in Europe.

Net income attributable to DENTSPLY International for the third quarter of 2013 was $79.9 million, or $0.55 per diluted share, compared to $53.4 million, or $0.37 per diluted share in the third quarter of 2012. On an adjusted basis, excluding certain items, earnings grew 12% to $0.57 per diluted share for the third quarter of 2013 from $0.51 in the same period in 2012. A reconciliation of the US GAAP measure to earnings per share calculated on a non-US GAAP basis is provided in the attached table.

DENTSPLY`s Chairman and Chief Executive Officer Bret Wise commented, "DENTSPLY made solid progress in the third quarter, achieving growth in each major geographic region and in each of our principal product categories. This growth, combined with strong improvement in adjusted operating margins and lower interest costs, drove record earnings for the third quarter. Market conditions are generally consistent with what we had anticipated earlier in the year, and thus we are maintaining our expectations for fiscal 2013 adjusted earnings per diluted share in the range of $2.33 to $2.38."

Additional Information

A conference call is scheduled to begin today at 8:30 a.m. (Eastern Time). Supplemental materials for reference during the call will be available for download in the investor relations section of DENTSPLY`s web site, at www.dentsply.com.

A live webcast will be accessible via a link on DENTSPLY`s web site at www.dentsply.com. In order to participate in the call, dial (877) 874-1588 for domestic calls, or (719) 325-4772 for international calls. The Conference ID # is 7195173. At that time, you will be able to discuss third quarter 2013 results with DENTSPLY`s Chairman and Chief Executive Officer, Bret Wise, President and Chief Financial Officer, Chris Clark, and Executive Vice President and Chief Operating Officer, Jim Mosch.

A rebroadcast of the conference call will be available online at the DENTSPLY web site. You may also access a dial-in replay for one week following the call at (888) 203-1112 (for domestic calls) or (719) 457-0820 (for international calls), Replay Passcode # 7195173

DENTSPLY International Inc. is a leading manufacturer and distributor of dental and other consumable medical device products. The Company believes it is the world`s largest manufacturer of consumable dental products for the professional dental market. For over 110 years, DENTSPLY`s commitment to innovation and professional collaboration has enhanced its portfolio of branded consumables and small equipment. Headquartered in the United States, the Company has global operations with sales in more than 120 countries. Visit www.dentsply.com for more information about DENTSPLY and its products.

This press release contains forward-looking information (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding future events or the future financial performance of the Company that involve substantial risks and uncertainties. Actual events or results may differ materially from those in the projections or other forward-looking information set forth herein as a result of certain risk factors. These risk factors include, without limitation; the continued strength of dental and medical markets, the timing, success and market reception for our new and existing products, uncertainty with respect to governmental actions with respect to dental and medical products, outcome of litigation and/or governmental enforcement actions, volatility in the capital markets or changes in our credit ratings, continued support of our products by influential dental and medical professionals, our ability to successfully integrate acquisitions, risks associated with foreign currency exchange rates, risks associated with our competitors` introduction of generic or private label products, our ability to accurately predict dealer and customer inventory levels, our ability to successfully realize the benefits of any cost reduction or restructuring efforts, our ability to obtain a supply of certain finished goods and raw materials from third parties and changes in the general economic environment that could affect the business. Changes in such assumptions or factors could produce significantly different results.

For additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements, please refer to the Company`s most recent Form 10-K and its subsequent periodic reports on Forms 10-Q filed with the Securities and Exchange Commission.

Non-US GAAP Financial Measures

In addition to the results reported in accordance with US GAAP, the Company provides adjusted net income attributable to DENTSPLY International and adjusted earnings per diluted common share. The Company discloses adjusted net income attributable to DENTSPLY International to allow investors to evaluate the performance of the Company`s operations exclusive of certain items that impact the comparability of results from period to period and certain large non-cash charges related to purchased intangible assets. The Company believes that this information is helpful in understanding underlying operating trends and cash flow generation. The adjusted net income attributable to DENTSPLY International consists of net income attributable to DENTSPLY International adjusted to exclude the impact of the following:

(1) Acquisition related costs. These adjustments include costs related to integrating recently acquired businesses and specific costs related to the consummation of the acquisition process. These costs are irregular in timing and as such may not be indicative of past and future performance of the Company and are therefore excluded to allow investors to better understand underlying operating trends.

(2) Restructuring and other costs, including legal settlements. These adjustments include both costs and income that are irregular in timing, amount and impact to the Company`s financial performance. As such, these items may not be indicative of past and future performance of the Company and are therefore excluded for the purpose of understanding underlying operating trends.

(3) Amortization of purchased intangible assets. This adjustment excludes the periodic amortization expense related to purchased intangible assets. Following a significant acquisition in 2011, the Company began recording large non-cash charges related to the values attributed to purchased intangible assets. These charges have been excluded from adjusted net income attributed to DENTSPLY International to allow investors to evaluate and understand operating trends excluding these large non-cash charges.

(4) Income related to credit risk and fair value adjustments. These adjustments include both the cost and income impacts of adjustments in certain assets and liabilities that are recorded through net income which are due solely to the changes in fair value and credit risk. These items can be variable and driven more by market conditions than the Company`s operating performance. As such, these items may not be indicative of past and future performance of the Company and therefore are excluded for comparability purposes.

(5) Certain fair value adjustments related to an unconsolidated affiliated company. This adjustment represents the fair value adjustment of the unconsolidated affiliated company`s convertible debt instrument held by the Company. The affiliate is accounted for under the equity method of accounting. The fair value adjustment is driven by open market pricing of the affiliate`s equity instruments, which has a high degree of variability and may not be indicative of the operating performance of the affiliate or the Company.

(6) Income tax related adjustments. These adjustments include both income tax expenses and income tax benefits that are representative of income tax adjustments mostly related to prior periods, as well as the final settlement of income tax audits. These adjustments are irregular in timing and amount and may significantly impact the Company`s operating performance. As such, these items may not be indicative of past and future performance of the Company and therefore are excluded for comparability purposes.

Adjusted earnings per diluted common share is calculated by dividing adjusted net income attributable to DENTSPLY International by diluted weighted-average common shares outstanding. Adjusted net income attributable to DENTSPLY International and adjusted earnings per diluted common share are considered measures not calculated in accordance with US GAAP, and therefore are non-US GAAP measures. These non-US GAAP measures may differ from other companies. Income tax related adjustments may include the impact to adjust the interim effective income tax rate to the expected annual effective tax rate. The non-US GAAP financial information should not be considered in isolation from, or as a substitute for, measures of financial performance prepared in accordance with US GAAP.

DENTSPLY INTERNATIONAL INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
Three Months EndedNine Months Ended
September 30,September 30,
2013201220132012
Net sales$704,018$695,734$2,197,112$2,175,141
Net sales, excluding precious metal content669,425647,1202,058,0292,011,225
Cost of products sold327,601331,6191,017,5391,010,807
Gross profit376,417364,1151,179,5731,164,334
% of Net sales53.5%52.3%53.7%53.5%
% of Net sales, excluding precious metal content56.2%56.3%57.3%57.9%
Selling, general and administrative expenses269,165260,352852,763860,740
Restructuring and other costs2,23115,0975,06518,862
Operating income105,02188,666321,745284,732
% of Net sales14.9%12.7%14.6%13.1%
% of Net sales, excluding precious metal content15.7%13.7%15.6%14.2%
Net interest and other expense10,88512,88540,33740,173
Income before income taxes94,13675,781281,408244,559
Provision for income taxes13,18718,96039,59948,550
Equity in net (loss) earnings of
unconsolidated affiliated company(83)(2,529)320(5,448)
Net income80,86654,292242,129190,561
% of Net sales11.5%7.8%11.0%8.8%
% of Net sales, excluding precious metal content12.1%8.4%11.8%9.5%
Less: Net income attributable to noncontrolling interests1,0159283,3663,148
Net income attributable to DENTSPLY International$79,851$53,364$238,763$187,413
% of Net sales11.3%7.7%10.9%8.6%
% of Net sales, excluding precious metal content11.9%8.2%11.6%9.3%
Earnings per common share:
Basic$0.56$0.38$1.67$1.32
Dilutive$0.55$0.37$1.65$1.30
Cash dividends declared per common share$0.0625$0.0550$0.1875$0.1650
Weighted average common shares outstanding:
Basic142,421141,843142,705141,767
Dilutive144,698143,884144,952143,885

DENTSPLY INTERNATIONAL INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
September 30,December 31,
20132012
Assets
Current Assets:
Cash and cash equivalents$50,658$80,132
Accounts and notes receivable-trade, net502,370442,412
Inventories, net448,277402,940
Prepaid expenses and other current assets151,840185,612
Total Current Assets1,153,1451,111,096
Property, plant and equipment, net628,509614,705
Identifiable intangible assets, net800,470830,642
Goodwill, net2,218,1362,210,953
Other noncurrent assets, net209,719204,901
Total Assets$5,009,979$4,972,297
Liabilities and Equity
Current liabilities$777,561$927,780
Long-term debt1,164,7941,222,035
Deferred income taxes226,668232,641
Other noncurrent liabilities361,938340,398
Total Liabilities2,530,9612,722,854
Total DENTSPLY International Equity2,438,4412,208,698
Noncontrolling interests40,57740,745
Total Equity2,479,0182,249,443
Total Liabilities and Equity$5,009,979$4,972,297

DENTSPLY INTERNATIONAL INC.
(In thousands)
Supplemental Summary Cash Flow Information:
Nine Months Ended September 30, 2013 and 2012
Nine Months Ended September 30,
20132012
Net Cash Provided by Operating Activities$258,266$202,065
Net Cash Used in Investing Activities$161,891$80,300
Net Cash Used in Financing Activities$124,650$145,585
Depreciation$61,545$59,509
Amortization$34,700$37,289
Capital Expenditures$73,500$64,859
Cash Dividends Paid$25,895$23,561

DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Income Summary:
The following tables present the reconciliation of reported US GAAP operating income in total and on a percentage of net sales, excluding precious metal content, to the non-US GAAP financial measures.
Three Months Ended September 30, 2013
Operating Income (Loss)Percentage of Net Sales, Excluding Precious Metal Content
Operating Income$105,02115.7%
Amortization of Purchased Intangible Assets11,2371.7%
Restructuring and Other Costs, including Legal Settlements2,2850.3%
Acquisition-Related Activities1,1730.2%
Adjusted Non-US GAAP Operating Income$119,71617.9%
Three Months Ended September 30, 2012
Operating Income (Loss)Percentage of Net Sales, Excluding Precious Metal Content
Operating Income$88,66613.7%
Restructuring and Other Costs15,4572.4%
Amortization of Purchased Intangible Assets9,3131.4%
Orthodontic Business Continuity Costs110-%
Acquisition-Related Activities(1,893)(0.2)%
Adjusted Non-US GAAP Operating Income$111,65317.3%
DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Income Summary:
The following tables present the reconciliation of reported US GAAP operating income in total and on a percentage of net sales, excluding precious metal content, to the non-US GAAP financial measures.
Nine Months Ended September 30, 2013
Operating Income (Loss)Percentage of Net Sales, Excluding Precious Metal Content
Operating Income$321,74515.6%
Amortization of Purchased Intangible Assets34,6521.7%
Restructuring and Other Costs, including Legal Settlements5,3430.3%
Acquisition-Related Activities4,4420.2%
Adjusted Non-US GAAP Operating Income$366,18217.8%
Nine Months Ended September 30, 2012
Operating Income (Loss)Percentage of Net Sales, Excluding Precious Metal Content
Operating Income$284,73214.2%
Amortization of Purchased Intangible Assets37,3591.9%
Restructuring and Other Costs20,0971.0%
Acquisition-Related Activities10,5440.5%
Orthodontics Business Continuity Costs1,071-%
Adjusted Non-US GAAP Operating Income$353,80317.6%

DENTSPLY INTERNATIONAL INC.
(In thousands, except per share amounts)
Earnings Summary:
The following tables present the reconciliation of reported US GAAP net income attributable to DENTSPLY International and on a per common share basis to the non-US GAAP financial measures.
Three Months Ended September 30, 2013
NetPer Diluted
IncomeCommon Share
Net Income Attributable to DENTSPLY International$79,851$0.55
Amortization of Purchased Intangible Assets, Net of Tax7,8510.06
Restructuring and Other Costs, including Legal Settlements, Net of Tax1,9610.01
Acquisition Related Activities, Net of Tax7440.01
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax(488)-
Gain on Fair Value Adjustments related to an Unconsolidated Affiliated Company, Net of Tax(829)(0.01)
Income Tax-Related Adjustments(6,882)(0.05)
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International$82,208$0.57
Three Months Ended September 30, 2012
NetPer Diluted
IncomeCommon Share
Net Income Attributable to DENTSPLY International$53,364$0.37
Restructuring and Other Costs, Net of Tax10,9090.08
Amortization of Purchased Intangible Assets, Net of Tax5,1590.04
Income Tax-Related Adjustments4,0390.03
Loss on Fair Value Adjustments related to an Unconsolidated Affiliated Company, Net of Tax1,6870.01
Orthodontics Business Continuity Costs, Net of Tax70-
Acquisition Related Activities, Net of Tax(1,161)(0.01)
Rounding-(0.01)
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International$74,067$0.51
DENTSPLY INTERNATIONAL INC.
(In thousands, except per share amounts)
Earnings Summary:
The following tables present the reconciliation of reported US GAAP net income attributable to DENTSPLY International and on a per common share basis to the non-US GAAP financial measures.
Nine Months Ended September 30, 2013
NetPer Diluted
IncomeCommon Share
Net Income Attributable to DENTSPLY International$238,763$1.65
Amortization of Purchased Intangible Assets, Net of Tax24,2290.17
Restructuring and Other Costs, including Legal Settlements, Net of Tax4,4620.03
Acquisition Related Activities, Net of Tax2,8430.02
Credit Risk and Fair Value Adjustments to Outstanding Derivatives, Net of Tax2,7020.02
Gain on Fair Value Adjustments related to an Unconsolidated Affiliated Company, Net of Tax(1,347)(0.01)
Income Tax-Related Adjustments(18,388)(0.13)
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International$253,264$1.75
Nine Months Ended September 30, 2012
NetPer Diluted
IncomeCommon Share
Net Income Attributable to DENTSPLY International$187,413$1.30
Amortization of Purchased Intangible Assets, Net of Tax25,1480.17
Restructuring and Other Costs, Net of Tax14,0630.10
Acquisition Related Activities, Net of Tax6,6300.05
Loss on Fair Value Adjustments related to an Unconsolidated Affiliated Company, Net of Tax5,2800.04
Orthodontics Business Continuity Costs, Net of Tax692-
Income Tax-Related Adjustments(1,375)(0.01)
Adjusted Non-US GAAP Net Income Attributable to DENTSPLY International$237,851$1.65

DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Tax Rate Summary:
The following tables present the reconciliation of reported US GAAP effective tax rate as a percentage of income before income taxes to the non-US GAAP financial measure.
Three Months Ended September 30, 2013
Pre-tax IncomeIncome Tax Benefit (Expense)Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results$94,136$(13,187)14.0%
Amortization of Purchased Intangible Assets11,237(3,386)
Restructuring and Other Costs, including Legal Settlements2,285(324)
Acquisition-Related Activities1,173(429)
Gain on Fair Value Adjustments related to an Unconsolidated Affiliated Company(8)2
Credit Risk and Fair Value Adjustments to Outstanding Derivatives(794)306
Income Tax-Related Adjustments-(6,882)
As Adjusted - Non-US GAAP Operating Results$108,029$(23,900)22.1%
Three Months Ended September 30, 2012
Pre-tax IncomeIncome Tax Benefit (Expense)Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results$75,781$(18,960)25.0%
Restructuring and Other Costs15,458(4,549)
Amortization of Purchased Intangible Assets9,313(4,154)
Orthodontics Business Continuity Costs110(40)
Gain on Fair Value Adjustments related to an Unconsolidated Affiliated Company(407)123
Acquisition-Related Activities(1,893)732
Income Tax-Related Adjustments-4,039
As Adjusted - Non-US GAAP Operating Results$98,362$(22,809)23.2%
DENTSPLY INTERNATIONAL INC.
(In thousands)
Operating Tax Rate Summary:
The following tables present the reconciliation of reported US GAAP effective tax rate as a percentage of income before income taxes to the non-US GAAP financial measure.
Nine Months Ended September 30, 2013
Pre-tax IncomeIncome Tax Benefit (Expense)Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results$281,408$(39,599)14.1%
Amortization of Purchased Intangible Assets34,652(10,423)
Restructuring and Other Costs, including Legal Settlements5,343(881)
Acquisition-Related Activities4,442(1,599)
Credit Risk and Fair Value Adjustments to Outstanding Derivatives4,401(1,699)
Gain on Fair Value Adjustments related to an Unconsolidated Affiliated Company(20)6
Income Tax-Related Adjustments-(18,388)
As Adjusted - Non-US GAAP Operating Results$330,226$(72,583)22.0%
Nine Months Ended September 30, 2012
Pre-tax IncomeIncome Tax Benefit (Expense)Percentage of Pre-Tax Income
As Reported - US GAAP Operating Results$244,559$(48,550)19.9%
Amortization of Purchased Intangible Assets37,359(12,211)
Restructuring and Other Costs20,098(6,035)
Acquisition-Related Activities10,544(3,914)
Orthodontics Business Continuity Costs1,071(379)
Loss on Fair Value Adjustments related to an Unconsolidated Affiliated Company(229)69
Income Tax-Related Adjustments-(1,375)
As Adjusted - Non-US GAAP Operating Results$313,402$(72,395)23.1%
For further information contact:

Derek Leckow
Vice President
Investor Relations
(717) 849-7863

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10